| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 6 Nov 2025 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September 2025 and to consider any other matter with the permission of the Board. Please take the same on your record. Thanking You Unaudited Financial Results for the Quarter ended on 30-09-2025. (As per BSE Announcement dated on: 14.11.2025) | ||
| Board Meeting | 14 Oct 2025 | 10 Oct 2025 |
| Inter alia, to consider and approve:- 1. To consider and approve the re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company, 2. To approve Notice of Postal Ballot 3. Appoint M/s. Amrish Gandhi & Associates, Practising Company Secretary scrutinizer to scrutinize the e-voting process in a fair and transparent manner for the postal ballot. 4. Any other businesses Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held on Tuesday, 14th October, 2025 has inter alia, considered and approved the following: 1. Re-appointment of Statutory Auditor: 2. Approval of Postal Ballot Notice: 3. Appointment of Scrutinizer: The Board Meeting commenced at 10:30 a.m. and concluded at 11:00 a.m. Do acknowledge the receipt of same and disseminate the above announcement on BSEs and NSEs Website. Thanking You, (As per BSE Announcement dated on: 14.10.2025) | ||
| Board Meeting | 28 Aug 2025 | 28 Aug 2025 |
| Outcome of BM | ||
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Unaudited financial results for the quarter ended on 30-06-2025. and Any other corporate matters as may discussed in the meeting. Dear Sir, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, 12th August, 2025 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter ended 30th June, 2025 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 14.00 P.M. and concluded at 14:30 P.M. You are requested to kindly take the same on record. Thanking you, (As Per BSE Announcement Dated on: 12/08/2025) | ||
| Board Meeting | 26 May 2025 | 17 May 2025 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended on 31-03-2025. Consider and Approve Audited Financial Results for the year ended on 31st March, 2025 (As per BSE Announcement Dated on 26/05/2025) | ||
| Board Meeting | 11 Feb 2025 | 3 Feb 2025 |
| Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited financial Results for the quarter ended on 31-12-2024. Financial Results (As Per BSE Announcement Dated on: 11/02/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.